Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: The action in diabetes and vascular disease: Preterax and diamicron modified release controlled evaluation (ADVANCE) trial

Diabetologia

Volumn 52, Issue 11, 2009, Pages 2328-2336

  De Galan, B E ^a,b   Zoungas, S ^a,c   Chalmers, J ^a   Anderson, C ^a   Dufouil, C ^d,e   Pillai, A ^a   Cooper, M ^f   Grobbee, D E ^g   Hackett, M ^a   Hamet, P ^h   Heller, S R ⁱ   Lisheng, L ^j   MacMahon, S ^a   Mancia, G ^k   Neal, B ^a   Pan, C Y ^l   Patel, A ^a   Poulter, N ^m   Travert, F ^e   Woodward, M ^a,n  

^a UNIVERSITY OF SYDNEY   (Australia)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MONASH UNIVERSITY   (Australia)

^d INSERM   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ UNIVERSITY OF SHEFFIELD   (United Kingdom)

^j Beijing Hypertension League Institute   (China)

^k SAN GERARDO HOSPITAL   (Italy)

^l CHINESE PLA GENERAL HOSPITAL   (China)

^m ST MARY S HOSPITAL   (United Kingdom)

ⁿ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Blood pressure control; Cardiovascular disease risk; Cognitive function; Glucose control; Hypoglycaemia; MMSE; Mortality; Type 2 diabetes

Indexed keywords

GLICLAZIDE; GLUCOSE; INDAPAMIDE PLUS PERINDOPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RELEASE; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; VASCULAR DISEASE;

AGED; ANTIHYPERTENSIVE AGENTS; COGNITION; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; EDUCATIONAL STATUS; FEMALE; GLICLAZIDE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INDAPAMIDE; MALE; MENTAL STATUS SCHEDULE; MYOCARDIAL INFARCTION; PERINDOPRIL; RISK FACTORS; STROKE;

EID: 70349850941     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1484-7     Document Type: Article

References (33)

1. CP Ferri M Prince C Brayne, et al. 2005 Global prevalence of dementia: a Delphi consensus study Lancet 366 2112 2117 16360788 10.1016/S0140-6736(05) 67889-0 (Pubitemid 41797645)
2. S Wild G Roglic A Green R Sicree H King 2004 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 1047 1053 15111519 10.2337/diacare.27.5.1047 (see comment) (Pubitemid 38579764)
3. T Cukierman-Yaffe HC Gerstein C Anderson, et al. 2009 Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme Diabetes Res Clin Pract 83 387 393 19157618 10.1016/j.diabres.2008.12.005 1:CAS:528:DC%2BD1MXhs1eitrs%3D
4. A Fontbonne C Berr P Ducimetiere A Alperovitch 2001 Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study Diabetes Care 24 366 370 11213894 10.2337/diacare.24.2.366 1:STN:280:DC%2BD3M7otVShsw%3D%3D
5. EW Gregg K Yaffe JA Cauley, et al. 2000 Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group Arch Intern Med 160 174 180 10647755 10.1001/archinte.160.2.174 1:STN:280:DC%2BD3c7ht1arsw%3D%3D (see comment)
6. T Cukierman-Yaffe HC Gerstein JD Williamson, et al. 2009 Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial Diabetes Care 32 221 226 19171735 10.2337/dc08-1153
7. T Cukierman HC Gerstein JD Williamson 2005 Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies Diabetologia 48 2460 2469 16283246 10.1007/s00125-005-0023-4 1:STN:280:DC%2BD2Mnjsl2ruw%3D%3D (Pubitemid 41738208)
8. CT Kodl ER Seaquist 2008 Cognitive dysfunction and diabetes mellitus Endocr Rev 29 494 511 18436709 10.1210/er.2007-0034 1:CAS:528: DC%2BD1cXosVGjsr4%3D (Pubitemid 351831510)
9. MM Breteler JJ Claus DE Grobbee A Hofman 1994 Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study BMJ 308 1604 1608 8025427 1:STN:280:DyaK2c3pslCisg%3D%3D (see comment)
10. L Ferrucci JM Guralnik ME Salive, et al. 1996 Cognitive impairment and risk of stroke in the older population J Am Geriatr Soc 44 237 241 8600190 1:STN:280:DyaK287osVKkug%3D%3D (see comment)
11. CR Gale CN Martyn C Cooper 1996 Cognitive impairment and mortality in a cohort of elderly people BMJ 312 608 611 8595334 1:STN:280:DyaK287nvFKhuw%3D%3D (Pubitemid 26079596)
12. I Skoog H Lithell L Hansson, et al. 2005 Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE) Am J Hypertens 18 1052 1059 16109319 10.1016/j.amjhyper.2005.02.013 1:CAS:528: DC%2BD2MXos1aisbs%3D (Pubitemid 41139903)
13. D Feil T Marmon J Unutzer 2003 Cognitive impairment, chronic medical illness, and risk of mortality in an elderly cohort Am J Geriatr Psychiatry 11 551 560 14506089
14. LC McGuire ES Ford UA Ajani 2006 The impact of cognitive functioning on mortality and the development of functional disability in older adults with diabetes: the second longitudinal study on aging BMC Geriatr 6 8 16650284 10.1186/1471-2318-6-8 (Pubitemid 43824660)
15. SE Nilsson S Read S Berg B Johansson A Melander U Lindblad 2007 Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older Aging Clin Exp Res 19 41 47 17332720
16. L Zhu M Viitanen Z Guo B Winblad L Fratiglioni 1998 Blood pressure reduction, cardiovascular diseases, and cognitive decline in the mini-mental state examination in a community population of normal very old people: a three-year follow-up J Clin Epidemiol 51 385 391 9619965 10.1016/S0895-4356(98) 00003-1 1:STN:280:DyaK1c3otFaltg%3D%3D (Pubitemid 28223304)
17. A Patel S MacMahon J Chalmers, et al. 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2560 2572 18539916 10.1056/NEJMicm066227 1:CAS:528:DC%2BD1cXnt1yht7s%3D (Pubitemid 351214289)
18. A Patel S MacMahon J Chalmers, et al. 2007 Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial Lancet 370 829 840 17765963 10.1016/S0140-6736(07)61303-8 1:CAS:528:DC%2BD2sXhtVWjs7zO (Pubitemid 47362321)
19. ADVANCE Management Committee 2001 Study rationale and design of ADVANCE: action in diabetes and vascular disease-preterax and diamicron MR controlled evaluation Diabetologia 44 1118 1120 10.1007/s001250100612 (Pubitemid 32835503)
20. RM Crum JC Anthony SS Bassett MF Folstein 1993 Population-based norms for the Mini-Mental State Examination by age and educational level JAMA 269 2386 2391 8479064 10.1001/jama.269.18.2386 1:STN:280:DyaK3s3ktVKkug%3D%3D (see comment) (Pubitemid 23129378)
21. MJ Sarnak AS Levey AC Schoolwerth, et al. 2003 Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 2154 2169 14581387 10.1161/01.CIR.0000095676.90936.80 (Pubitemid 37337595)
22. JS Elkins DS Knopman K Yaffe SC Johnston 2005 Cognitive function predicts first-time stroke and heart disease Neurology 64 1750 1755 15911803 10.1212/01.WNL.0000161850.01792.77 (Pubitemid 40695810)
23. GD Batty EL Mortensen AM Nybo Andersen M Osler 2005 Childhood intelligence in relation to adult coronary heart disease and stroke risk: evidence from a Danish birth cohort study Paediatr Perinat Epidemiol 19 452 459 16269073 10.1111/j.1365-3016.2005.00671.x (Pubitemid 41687398)
24. GD Batty KM Wennerstad GD Smith, et al. 2009 IQ in early adulthood and mortality by middle age: cohort study of 1 million Swedish men Epidemiology 20 100 109 19234402 10.1097/EDE.0b013e31818ba076
25. LC Perlmuter MK Hakami C Hodgson-Harrington, et al. 1984 Decreased cognitive function in aging non-insulin-dependent diabetic patients Am J Med 77 1043 1048 6334441 10.1016/0002-9343(84)90186-4 1:STN:280:DyaL2M%2FmvFGhtw%3D%3D (Pubitemid 15221767)
26. RP Stolk MM Breteler A Ott, et al. 1997 Insulin and cognitive function in an elderly population. The Rotterdam Study Diabetes Care 20 792 795 9135944 10.2337/diacare.20.5.792 1:STN:280:DyaK2s3otFKgtA%3D%3D
27. G Hu Q Qiao J Tuomilehto, et al. 2004 Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies Diabetologia 47 1245 1256 15241592 1:STN:280:DC%2BD2cvktVKktg%3D%3D
28. Rönnemaa E, Zethelius B, Sundelof J et al (2009) Glucose metabolism and the risk of Alzheimer's disease and dementia: a population-based 12 year follow-up study in 71-year-old men. Diabetologia 52:1504-1510
29. G Howard DH O'Leary D Zaccaro, et al. 1996 Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators Circulation 93 1809 1817 8635260 1:CAS:528:DyaK28Xjs1Sku78%3D
30. GD Baura DM Foster K Kaiyala D Porte Jr SE Kahn MW Schwartz 1996 Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs Diabetes 45 86 90 8522065 10.2337/diabetes.45.1.86 1:CAS:528:DyaK28XhvFarsg%3D%3D
31. K Anthony LJ Reed JT Dunn, et al. 2006 Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome? Diabetes 55 2986 2992 17065334 10.2337/db06-0376 1:CAS:528: DC%2BD28XhtF2rsbfI (Pubitemid 44923634)
32. MA Fishel GS Watson TJ Montine, et al. 2005 Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults Arch Neurol 62 1539 1544 16216936 10.1001/archneur.62.10.noc50112 (Pubitemid 41434558)
33. MF Folstein SE Folstein PR McHugh 1975 Mini-mental state. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189 198 1202204 10.1016/0022-3956(75)90026-6 1:STN:280: DyaE28%2FntFKjtw%3D%3D